An experimental gene therapy could offer new hope for patients living with retinitis pigmentosa, a group of inherited retinal diseases that can lead to progressive vision loss. Sulagna Bhattacharya, co founder and CEO of Nano Scope Therapeutics, shares how her own family’s experience with RP inspired her mission to develop new treatment options.
Bhattacharya explains why retinitis pigmentosa has been particularly challenging to treat. Because...
This video explores common risks in cryptocurrency investing, such as social engineering scams, and warns against the dangers of emotional day trading (0:26-9:00). To...
Andrew Kang is a veteran crypto investor and the CEO of RoboStrategy, a publicly traded closed-end fund focused on the robotics industry (Nasdaq: BOT)....
Copper CRO Simon Morgan joins host Rachel for a wide-ranging conversation about how the company has transformed from a straightforward digital asset custodian into...
Hugh Baker, Chief Financial Officer at ADNOC Logistics & Services, joins Johny Fernandez at the NYSE to discuss the company’s outlook and earnings trajectory,...